Wenyao Zhen

9PUBLICATIONS
25CO-AUTHORS
BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsBiologically active moleculesNanochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 17, 2026
Albumin binding improves the pharmacokinetics and therapeutic efficacy of a 177Lu-labeled HER2 Fab radioconjugate.

|Feb 23, 2026
MSA-2 Loaded Three-Dimensional Metal Covalent Organic Framework for Synergistic Radiosensitization and Innate Immune Activation.

Wenyao Zhen, Wang-Kang Han, Tianzhi Zhao

|Nov 15, 2024
Inflammasome-Activating Nanovaccine for Cancer Immunotherapy.

Wenyao Zhen, Xiaoyuan Chen

|Jul 17, 2024
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition.

Xiaomin Jiang, Taokun Luo, Kaiting Yang

|Mar 20, 2023
Glutathione-Induced In Situ Michael Addition between Nanoparticles for Pyroptosis and Immunotherapy.

Wenyao Zhen, Yang Liu, Shangjie An

|Sep 22, 2022
Dynamic surface properties of PEG-coated CuS nanoparticles alter their interaction with cells as revealed by surface-enhanced infrared spectroscopy.

Fengjuan Cao, Lie Wu, Xiaofei Zhang

Pageof 2

Frequent Collaborators

5 joint publications

Xiue Jiang

3 joint publications

Xiaoyuan Chen

2 joint publications

Jingjing Zhang

2 joint publications

Tianzhi Zhao